XML 17 R4.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 25, 2021
Dec. 26, 2020
Dec. 28, 2019
Revenues:      
Total revenues $ 45,666,117 $ 40,127,669 $ 29,518,809
Expenses:      
Cost of product revenues 25,052,383 21,398,381 20,901,538
Research and development-funded programs 9,976,103 7,745,762 4,216,161
Research and development-internal 6,312,148 3,924,241 9,132,969
Selling, general and administrative 18,100,519 11,822,703 21,316,459
Impairment of goodwill 331,344
Total operating expenses 59,441,153 44,891,087 55,898,471
Loss from operations (13,775,036) (4,763,418) (26,379,662)
Non-operating income (expense), net:      
Interest income 31,142 132,642 543,759
Other income (expense), net 265,509 (35,463) 225,617
Foreign currency transaction gains 139,014 293,670 202,517
Loss on investments (29,356) (3,858,453)
Total non-operating income (expense) 435,665 361,493 (2,886,560)
Loss before provision for income taxes and net loss (income) of noncontrolling interest (13,339,371) (4,401,925) (29,266,222)
Tax provision (129,000) (129,000) (108,000)
Net loss (13,468,371) (4,530,925) (29,374,222)
Net loss (income) attributable to the noncontrolling interest 35,498 119,813 (132,030)
Net loss attributable to Kopin Corporation $ (13,432,873) $ (4,411,112) $ (29,506,252)
Net loss per share:      
Basic and diluted $ (0.15) $ (0.05) $ (0.37)
Weighted average number of common shares outstanding:      
Basic and diluted 88,903,658 82,347,741 80,282,126
Net Product Revenues [Member]      
Revenues:      
Total revenues $ 29,882,271 $ 28,517,874 $ 20,283,888
Research and Development Revenues [Member]      
Revenues:      
Total revenues 14,668,471 10,122,677 4,982,868
License and Other Revenues [Member]      
Revenues:      
Total revenues $ 1,115,375 $ 1,487,118 $ 4,252,053